189 results
Page 2 of 10
6-K
EX-99.1
snw jgdi9y3n7zxce
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
4b7dxgj8wrbhs6eh
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.2
mld7w9d rzgua
25 Oct 22
Current report (foreign)
12:27pm
20-F/A
vz0favcas51b
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
64ulrzg3
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.2
nvzdj4
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
u1isus6jg0fh
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
twdb9i6l3c o1or
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.3
mknesv r0bp
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
fljg0f
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
xurxd7 rli8ztq
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
zr7g8knqpi wx
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.4
s5xslt
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
h4mjkwj kj
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
rrovc6fo5owq0w1zt
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
on3nni4c7sd136x
17 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
12:35pm
6-K
EX-99.1
ya9kmgmu9jvgsgwm
2 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
2:03pm
6-K
EX-99.1
ykenw1f24b 4xk44
17 May 22
Replicel Life Sciences Inc. Provides Default Status Update
6:51pm
6-K
EX-99.4
e9t2q8lgc0x2mo5
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm